KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Working Capital Changes (2016 - 2025)

Sarepta Therapeutics has reported Other Working Capital Changes over the past 13 years, most recently at -$20.3 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$20.3 million for Q4 2025, up 71.64% from a year ago — trailing twelve months through Dec 2025 was $79.8 million (up 348.08% YoY), and the annual figure for FY2025 was $69569.0, up 100.22%.
  • Other Working Capital Changes for Q4 2025 was -$20.3 million at Sarepta Therapeutics, down from $159.9 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for SRPT hit a ceiling of $159.9 million in Q3 2025 and a floor of -$85.4 million in Q1 2025.
  • Median Other Working Capital Changes over the past 5 years was -$21.1 million (2022), compared with a mean of -$5.7 million.
  • Biggest five-year swings in Other Working Capital Changes: surged 271.0% in 2022 and later plummeted 3788.86% in 2025.
  • Sarepta Therapeutics' Other Working Capital Changes stood at -$36.5 million in 2021, then surged by 271.0% to $62.3 million in 2022, then crashed by 132.21% to -$20.1 million in 2023, then tumbled by 256.31% to -$71.5 million in 2024, then soared by 71.64% to -$20.3 million in 2025.
  • The last three reported values for Other Working Capital Changes were -$20.3 million (Q4 2025), $159.9 million (Q3 2025), and $25.6 million (Q2 2025) per Business Quant data.